An INTREPID journey into the epidemiological landscape of psychosis in the Global South

jen-theodore-tWqyWrqLntU-unsplash

Shuichi Suetani and Jon Paul Teo discuss the International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II) study, which investigates the epidemiology of untreated psychoses in 3 diverse settings in the Global South.

[read the full story...]

Antipsychotics for acute treatment of first episode schizophrenia

Creative-Tail-medicine.svg

Elwira Lubos writes her debut blog on a recent systematic review with pairwise and network meta-analyses, looking at antipsychotic drugs for the acute treatment of patients with first episode schizophrenia.

[read the full story...]

Omega-3 fatty acids to prevent psychosis: the importance of replication (NEURAPRO trial)

22421169767_03c5cce9cf_z

Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.

[read the full story...]

Outcomes in first episode manic psychosis

photo-1423420634464-89006b3454a8

Matthew Broome writes his debut Mental Elf blog on a three-year clinical and functional outcome comparison between first episode manic psychosis and first-episode schizophrenia.

[read the full story...]

Prognosis of brief psychotic episodes

3917186281_bb24ceabb8_o

Samei Huda presents the findings of a new meta-analysis, which explores the prognostic significance of competing ways of defining and measuring brief psychotic episodes.

[read the full story...]